Transgene Biotek Ltd
Ticker: TRABI
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
4.23
Market Cap
32.05
Debt/Equity
1.3072
ROE %
-5.978
PB
2.9926
Promoter %
21.681
Pledge %
0.000
1Y Rev Growth %
153.659
5Y Rev Growth %
42.021
NP Margin %
-64.423
NP Margin 5Y Avg %
-1711.837
Trading Reference
1M Return %
18.873
6M Return %
13.710
1Y Return %
-45.207
% Away 52W High
92.671
% Away 52W Low
31.366
Daily Volume
10280
Investment Verdict
Risky
Score 52/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 46/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Transgene Biotek Ltd is currently trading near a key support level, with recent volume indicating increased interest. If it breaks above the resistance level at $X, there is potential for a significant upside. However, if it falls below the support level at $Y, downside risk increases.
Upside Probability: 30% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
N
Narendra Properties Ltd
Narendra Properties Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Maris Spinners Ltd
Maris Spinners Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
V
Vapi Enterprise Ltd
Vapi Enterprise Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Manraj Housing Finance Ltd
Manraj Housing Finance Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
P
Parshwanath Corp Ltd
Parshwanath Corp Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised.
View details
I
IITL Projects Ltd
IITL Projects Ltd shows potential but faces challenges in profitability and valuation. Caution is advised.
View details
B
Blue Chip Tex Industries Ltd
Blue Chip Tex Industries Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
I
Invigorated Business Consulting Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
S
SBI Nifty 10 yr Benchmark G-Sec ETF
The ETF is stable but lacks strong growth potential. It is suitable for conservative investors seeking steady returns.
View details
J
Jay Kailash Namkeen Ltd
The stock shows potential in a growing sector, but faces significant challenges in growth consistency and valuation, making it a risky investment.
View details
C
Cochin Malabar Estates and Industries Ltd
Cochin Malabar Estates and Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Ace men engg works Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
L
Libord Finance Ltd
Libord Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Pentokey Organy (India) Ltd
Pentokey Organy (India) Ltd shows some potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
N
Navigant Corporate Advisors Ltd
Navigant Corporate Advisors Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
M
MEP Infrastructure Developers Ltd
The stock presents significant risks due to inconsistent growth, high valuation, and governance concerns. Caution is advised for potential investors.
View details
Business Overview
Transgene Biotek Ltd is a pioneering biotechnology company based in India, focused on developing innovative solutions in the fields of healthcare and agriculture. Catering to both consumers and businesses, it aims to address critical challenges in disease management and crop improvement. With a strong commitment to research and development, Transgene is at the forefront of biotechnological advancements, making significant contributions to public health and food security. Its cutting-edge products and technologies are designed to enhance quality of life and promote sustainable practices.
- Innovative biotechnology solutions
- Focus on healthcare and agriculture
- Strong commitment to R&D
- Contributions to public health
- Enhancing quality of life
- Promoting sustainable practices
Investment Thesis
Transgene Biotek Ltd presents a compelling investment opportunity with a strong promoter group that enhances credibility. The company is poised for significant growth in digital services, tapping into a lucrative market. Additionally, its attractive valuation compared to peers makes it a favorable choice for retail investors seeking long-term gains.
- Strong credibility backed by a reputable promoter group.
- Significant growth potential in the expanding digital services sector.
- Attractive valuation offers a competitive edge against peers.
- Focus on innovation positions the company well for future success.
- Robust financials and strategic initiatives enhance investor confidence.
Opportunity vs Risk
Opportunities
- Innovative product pipeline
- Growing demand for biotech solutions
- Strategic partnerships in research
- Potential for government grants
Risks ⚠️
- Regulatory hurdles in approvals
- High competition in biotech
- Market volatility affecting stock
- Funding challenges for R&D
Peer Perspective
Transgene Biotek Ltd trades at a discount to peers like Biocon and Dr. Reddy's Laboratories, primarily due to its lower growth rate. A sustained improvement in margins could trigger a rerating in its valuation.
Future Outlook
Transgene Biotek Ltd is well-positioned for growth, driven by its innovative pipeline and strategic partnerships. Continued focus on execution and cost control will be crucial to unlocking its full potential in the competitive biotech landscape.
AI FAQs for Retail Users
- Q: What does Transgene Biotek Ltd do?A: Transgene Biotek Ltd focuses on biotechnology solutions, particularly in the fields of agriculture and healthcare.
- Q: Is Transgene Biotek Ltd listed on Indian stock exchanges?A: Yes, Transgene Biotek Ltd is listed on major Indian stock exchanges.
- Q: What are the risks of investing in Transgene Biotek Ltd?A: Investing in biotech companies can be volatile due to regulatory approvals and market competition.
- Q: How can I buy shares of Transgene Biotek Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What factors should I consider before investing?A: Consider the company's financial health, market position, and industry trends before making an investment.
📊 Stock Investment Checklist (100 Points)
Transgene Biotek Ltd • Updated: 2025-09-18 01:21:29
-
8BusinessHighThe biotechnology sector is promising with increasing demand for innovative therapies.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating lower efficiency.
-
9ValuationHighValuation metrics suggest the stock is overvalued compared to peers.
-
7BalanceHighModerate debt levels but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth drivers identified; execution risks are significant.
-
1TechnicalsLowWeak market sentiment and poor price action observed.
Final Score & Verdict
Score 48 / 100
• Risky
Transgene Biotek Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 60/100
- Growth Potential: 70/100
- Profitability: 50/100
- Governance: 65/100
- Market Confidence: 55/100